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Abstract
Background: Alendronate (ALD) is a member of the bisphosphonate family which is used for the treatment of
osteoporosis, bone metastasis, Paget’s disease, hypocalcaemia associated with malignancy and other conditions
that feature bone fragility. ALD is a non-chromophoric compound so its determination by conventional
spectrophotometric methods is not possible. So two derivatization reactions were proposed for determination of
ALD through the reaction with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) and 2,4-dinitrofluorobenzene
(DNFB) as chromogenic derivatizing reagents.
Results: Three simple and sensitive spectrophotometric methods are described for the determination of ALD.
Method I is based on the reaction of ALD with NBD-Cl. Method II involved heat-catalyzed derivatization of ALD
with DNFB, while, Method III is based on micellar-catalyzed reaction of the studied drug with DNFB at room
temperature. The reactions products were measured at 472, 378 and 374 nm, for methods I, II and III, respectively.
Beer’s law was obeyed over the concentration ranges of 1.0-20.0, 4.0-40.0 and 1.5-30.0 μg/mL with lower limits of
detection of 0.09, 1.06 and 0.06 μg/mL for Methods I, II and III, respectively. The proposed methods were applied
for quantitation of the studied drug in its pure form with mean percentage recoveries of 100.47 ± 1.12, 100.17 ±
1.21 and 99.23 ± 1.26 for Methods I, II and III, respectively. Moreover the proposed methods were successfully
applied for determination of ALD in different tablets. Proposals of the reactions pathways have been postulated.
Conclusion: The proposed spectrophotometric methods provided sensitive, specific and inexpensive analytical
procedures for determination of the non-chromophoric drug alendronate either per se or in its tablet dosage
forms without interference from common excipients.
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Bisphosphonates is the name given to a group of drugs
characterized by a geminal bisphosphonate bond [1].
From the clinical point of view, bisphosphonates are used
for the treatment of osteoporosis, bone metastasis,
Paget’s disease, hypocalcaemia associated with malig-
nancy and other conditions that feature bone fragility [2].
Among bisphosphonates, one of the most popular
first-line drugs is alendronate sodium trihydrate (ALD).
ALD is designated chemically as (4-amino-1-hydroxybu-
tylidene) biphosphonic acid monosodium salt trihydrate
[3] (Figure 1). The two phosphonic groups per molecule
lend a strongly ionic character to ALD and increased
polarity. Additionally, ALD does not possess an appreci-
able chromophore; hence its determination by ordinary
spectrophotometric methods is not possible.
ALD is the subject of a monograph in both the British
pharmacopoeia (BP) [3] and the United States Pharma-
copoeia (USP) [4]. The BP [3] describes an HPLC
method with refractive index detection for determina-
tion of ALD in its pure form, while The USP [4] recom-
m e n d sa nH P L Cm e t h o dw i t hU V - d e t e c t i o na f t e r
derivatization with 9-fluorenylmethyl chloroformate for
its determination, whether in its pure form and in
tablets. Several methods have been presented in the lit-
erature for the determination of ALD. These include
spectrophotometry through complex formation [5,6],
oxidation with ceric (IV) sulfate [7] and derivatization of
its free primary amino group [7,8]. Also the molybdova-
nadate approach was employed for the determination of
ALD in tablets by spectrophotometry [9]. Furthermore,
titrimetry [10-12], liquid chromatography with different
modes of detection [9,13-23], capillary electrophoresis
[24-26] and stopped flow spectrofluorimetric methods
[27] have been applied for the determination of ALD.
Since ALD has no functional group that enables
absorption in the UV-visible region, so we decided to
analyze the drug through derivatization reactions. In this
approach, two different labeling agents, namely; 4-
chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) and 2,4-
dinitrofluorobenzene (DNFB, Sanger’s reagent) have been
used in derivatization reactions based on their reaction
with the free primary amino group of ALD.
Both reagents are well known to react with primary and
secondary amines forming stable condensation colored
products [28]. NBD-Cl, as an electroactive halide reagent,
was first introduced as an analytical reagent for the deter-
mination of some amines and amino acids. In recent
reports, NBD-Cl was further used as a chromogenic
reagent for the determination of some primary and sec-
ondary amines [29-34]. DNFB has been applied as a chro-
mophore reactant in the spectrophotometric determi-
nation of some compounds. The reaction of DNFB with
amines proceeds very slowly at room temperature. Such
reaction could be catalyzed by heating [33,35,36] or by
addition of micellar solution [37-39].
T h ea i mo ft h ep r e s e n ts t u d yw a st oo p t i m i z et h e
reaction of ALD with both NBD-Cl and DNFB. The
reaction of ALD with DNFB was enhanced by either
heating at 60°C or by the addition of cetrimide as a
cationic surfactant to the reaction mixture. The applic-
ability of the developed methods was evaluated through
the determination of ALD in pure form and tablet
formulations.
Experimental
Instruments
-A Shimadzu UV-Visible 1601 PC spectrophotometer
(Kyoto, Japan) was used for spectrophotometric measure-
ments (P/N 206-67001). The recording range was 0-1.0
-A consort NV P901 digital pH meter (Belgium) cali-
brated with standard buffers was used for checking the
pH of the buffer solutions used.
Reagents and materials
All the reagents used were of analytical grade and dis-
tilled water was used throughout the work.
-Amriya Pharm. Ind. CO. (Alexandria, Egypt) kindly
supplied a pure sample of alendronate sodium trihydrate
(with a purity of 100.55% as determined by the compari-
son method [7]) (Batch # AAS0400010).
-NBD-Cl (Aldrich Chemical Co. Ltd., USA) was
freshly prepared as 0.2% (w/v) methanolic solution.
-DNFB (Fluka chemica, USA) solution was freshly pre-
pared as 0.3% (v/v) in methanol, for both methods II
and III.
-Cetyltrimethylammonium bromide (cetrimide) was
obtained from Merck (Darmstadt, Germany), 1% (w/v)
aqueous solution was prepared.
-Sodium dodecyl sulphate (SDS, 95%) was obtained
from Winlab (Middlesex, England). 1% (w/v) aqueous
solution was prepared.
-Methanol, concentrated hydrochloric acid, sodium
hydroxide, boric acid and tween-80 (1%w/v aqueous
C PO3HNa
OH
H2O3P
(CH2)3
NH2
. 3 H2O
Figure 1 Chemical structure of alendronate sodium trihydrate
(ALD).
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Co. (ADWIC), Abu Zabaal, Egypt.
-Borate buffer solutions (0.2 M) were prepared by
mixing appropriate volumes of 0.2 M boric acid and
0.2 M NaOH and adjusting the pH to 10.0, 10.5 and
10.7 using a pH meter [40].
-The following tablets containing the drug were pur-
chased from local pharmacies:
■ Osteonate
® tablets (batch # 060181) labeled to con-
tain 10 mg alendronic acid equivalent to 13.05 mg
alendronate sodium trihydrate, product of the Egyptian
Co. For Chemicals and Pharmaceuticals (ADWIA) S.A.
E, 10
th of Ramadan City, Egypt.
■ Alendex
® tablets (batch # 6038) labeled to contain
40 mg of alendronic acid equivalent to 52.2 mg alen-
dronate sodium trihydrate, product of Uni Pharma
Co., Al Obour City, Cairo, Egypt.
Standard solutions
Standard solutions of ALD were prepared by dissolving
20.0, 40.0 and 30.0 mg of ALD in 100 mL distilled
water for methods I, II and III, respectively. These solu-
tions were stable for at least 10 days when stored in the
refrigerator. Working solutions were obtained by appro-
priate dilution.
General recommended procedures
Construction of calibration graphs
i. Method I To a set of 10-mL volumetric flasks, aliquot
volumes containing the drug in the working concentra-
tion range of 1.0-20.0 μg/mL were quantitatively trans-
ferred. To each flask 1 mL of borate buffer (pH 10.7)
followed by 1.2 mL of NBD-Cl solution (0.2% w/v) were
added and mixed well. The solutions were heated in ther-
mostatically controlled water bath at 70°C for 25 min.
The reaction was stopped by cooling under tap water,
then 0.2 mL of concentrated HCl was added and the
solutions were made up to volume with methanol. The
absorbance was measured at 472 nm against a reagent
blank. The calibration graph was constructed by plotting
the absorbance versus the final concentration of the drug
(μg/mL). Alternatively, the corresponding regression
equation was derived.
ii. Method II To a set of 10-mL volumetric flasks, aliquot
volumes containing the drug over the working concentra-
tion range of 4.0-40.0 μg/mL were quantitatively trans-
ferred. To each flask 1 mL of borate buffer (pH 10.5)
followed by 1.2 mL of DNFB solution (0.3% v/v) were
added and mixed well. The solutions were heated in ther-
mostatically controlled water bath at 60°C for 15 min. The
reaction was stopped by cooling under tap water, then
0.2 mL of concentrated HCl was added and the flasks
were made up to volume with water. The absorbance was
measured at 378 nm against a reagent blank. The absor-
bance was plotted versus the final concentration of the
drug (μg/mL) to obtain the calibration graph. Alterna-
tively, the corresponding regression equation was derived.
iii. Method III To a set of 10-mL volumetric flasks, ali-
quot volumes containing the drug over the working
concentration range of 1.5-30.0 μg/mL were quantita-
tively transferred. A volume of 1 mL of 0.2 M borate
buffer (pH 10.0) was added to each flask followed by 0.8
mL of 1% w/v cetrimide solution and 1 mL of DNFB
solution (0.3% v/v). The solutions were mixed well and
left at room temperature for 5 min before the addition
of 0.2 mL of concentrated HCl to all the flasks. The
volumes were completed using distilled water. The
absorbance was measured at 374 nm against a reagent
blank. The absorbance was plotted versus the final con-
centration of the drug (μg/mL) to obtain the calibration
graph. Alternatively, the corresponding regression equa-
tion was derived.
Assay procedure for tablets
Ten tablets were accurately weighed, finely powdered and
mixed well. A portion of the powder equivalent to 20.0
mg (method I), 40.0 mg (method II) and 30.0 mg
(method III) of ALD was transferred into100-mL volu-
metric flasks, about 80 mL distilled water was added to
each flask and they were sonicated for 15 min. The
volume was completed with water, mixed and filtered.
Aliquots covering the working concentration ranges cited
in Table 1 were transferred into 10-mL volumetric flasks.
The procedures described under “Construction of cali-
bration graphs” were followed adopting any of the three
methods. The nominal contents of the tablets were calcu-
lated using the corresponding regression equation.
Results and discussion
Method I
ALD is a primary aliphatic amino derivative that was
found to react with NBD-Cl with the formation of a yel-
low adduct. Under the described experimental condi-
tions, the yellow adduct has a characteristic absorption
spectrum with maximum absorbance at 472 nm as
shown in Figure 2.
Study of experimental parameters
The experimental conditions were studied by varying
each parameter individually and noting its effect on the
absorbance of the product.
i. Effect of pH and volume of buffer The pH depen-
dence of the system was studied over the range of 7.0-11.0
using 0.2 M borate buffer. Maximum absorption intensity
was obtained at pH 10.7 ± 0.2. Therefore, pH 10.7 was
chosen as the optimum pH for such study (Figure 3).
Maximum absorption intensity was obtained upon using
1 ± 0.5 mL of the buffer solution (Figure 4). Other buffers
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and phosphate buffer were attempted and compared with
0.2 M borate buffer. Borate buffer was found to be super-
ior to others as revealed by the high absorption intensity.
This different response to different buffers may be attribu-
ted to the slow rate of hydrolysis of NBD-Cl to NBD-OH
in borate buffer. This result is in agreement with that of
Miyano H. et al. [41].
ii. Effect of concentration of NBD-Cl solution The
influence of NBD-Cl concentration was studied using dif-
ferent volumes of 0.2% w/v solution of the reagent. It was
found that increasing volumes of the reagent produce a
Table 1 Analytical performance data for the proposed methods
Parameter Method I Method II Method III
Concentration range (μg/mL) 1.0-20.0 4.0-40.0 1.5-30.0
Limit of detection (LOD) (μg/ml) 0.09 1.06 0.06
Limit of quantification (LOQ) (μg/mL) 0.26 3.2 0.18
Correlation coefficient (r) 0.9998 0.9995 0.9996
Slope 0.0392 0.0150 0.0384
Intercept 0.0167 0.0134 -0.0401
Standard deviation of the residuals (Sy/x) 7.80 × 10
-3 6.74 × 10
-3 1.00 × 10
-2
Standard deviation of the intercept (Sa) 1×1 0
-3 4.80 × 10
-3 6.98 × 10
-4
Standard deviation of the slope (Sb) 4.67 × 10
-4 2.36 × 10
-4 4.80 × 10
-4
%RSD 1.11 1.21 1.27
% Error (% RSD/√n) 0.45 0.54 0.52
Molar absorptivity (ε) (l/mol./cm.) 1.32 × 10
4 5.2 × 10
3 1.22 × 10
4
Figure 2 Absorption spectra of the reactions products: (a) ALD (20 μg/mL) with NBD-Cl(Method I), (b) ALD (20 μg/mL) with DNFB
(Method II), (c) ALD (18 μg/mL) with DNFB (Method III).
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1 mL. However, no further increase in the absorption
intensity was observed upon increasing the volume of the
reagent up to 1.5 mL, after which further increase pro-
duced a gradual decrease in the absorption intensity.
Therefore, 1.2 mL of 0.2% w/v NBD-Cl solution was cho-
sen as the optimal volume of the reagent (Figure 5). The
absorption value of the hydrolysis product of NBD-Cl,
namely, 4-hydroxy-7-nitro-benzo-2-oxa-1,3-diazole
(NBD-OH), is quenched by decreasing the pH of the
reaction medium to less than 1 by adding 0.2 mL of con-
centrated HCl. Therefore, acidification of the reaction
mixture prior to measurement of the absorbance value
remarkably decreased the background absorbance due to
the formation of NBD-OH without affecting the drug-
reagent adduct, hence the sensitivity was increased [42].
iii. Effect of heating temperature and heating time
Preliminary studies revealed that the reaction rate was
very slow at room temperature. In this study, the reaction
was performed at different temperatures for various time
intervals. As it is seen in Figure 6A, the reaction was
completed at 70°C within 25 ± 5 min. Increasing the tem-
perature to 80°C resulted in an apparent decrease in the
absorption intensity.
iv. Effect of diluting solvent The effect of diluting sol-
vent was tested using different solvents viz water, metha-
nol, acetone, acetonitrile, dimethylformamide and
isopropanol. Using water as diluting solvent gives the
highest absorbance value. However, the reproducibility
upon using this diluting solvent was found to be adversely
affected. Of all the diluting solvents studied, methanol was
chosen as the best one since it gave reasonable absorption
intensity with maximum product stability.
v. Effect of time on the stability of the formed adduct
Regarding the stability of the produced derivative, it was
found to be stable at room temperature for approxi-
mately 1 h after which it faded slowly.
Method II
The analytical applications of 2,4-dinitrofluorobenzene
(DNFB) for the assay and characterization of specific
functional groups such as primary and secondary
amines, phenols, thiols and imidazoles have been estab-
lished by Connor [43]. In the present work, DNFB
reacts through a nucleophilic aromatic substitution reac-
tion with the primary aliphatic amino group of ALD in
aqueous alkaline medium. The reaction between ALD
and DNFB is very slow at room temperature and
required heating to speed it up. A yellow colored pro-
duct peaking at 378 nm is produced (Figure 2).
Study of experimental parameters
The experimental conditions for the derivatization reac-
tion were optimized by the univariate method (changing
one parameter at each step).
i. Effect of pH and volume of buffer The reaction was
investigated over the pH range of 7.0-11.0 using 0.2 M
borate buffer. The product showed the highest absorp-
tion in buffer of pH 10.5 ± 0.5 (Figure 3). Therefore, pH
10.5 was selected as the optimum pH for such reaction.
It was found that increasing the volume of the buffer pro-
duces a corresponding increase in the absorbance value
of the reaction product up to 0.5 mL, and it remained
constant up to 1.5 mL (Figure 4). Therefore, 1 mL was
chosen as the optimum buffer volume.
ii. Effect of concentration of DNFB solution The influ-
ence of the concentration of DNFB was studied using
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Figure 3 Effect of the pH of 0.2 M borate buffer on the reaction of: ■ ALD (15 μg/mL) with NBD-Cl, ▲ ALD (40 μg/mL) with DNFB
(method II), ● ALD (15 μg/mL) with DNFB (method III).
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was found that increasing volumes of the reagent pro-
duce a proportional increase in the absorption intensity
up to 1 mL. However, no further increase in the absorp-
tion intensity was observed upon increasing the volume
of the reagent up to 1.5 mL, after which further increase
produces a gradual decrease in the absorption intensity.
Therefore, 1.2 mL of 0.3% v/v DNFB solution was cho-
sen as the optimal volume of the reagent (Figure 5). To
remove the excess reagent interference in the absor-
bance measurement of the reaction product, this excess
was acid-hydrolyzed to colorless 2,4-dinitrophenol by
adding 0.2 mL of concentrated HCl allowing the mea-
surement of ALD-DNFB derivative which remains
stable.
iii. Effect of heating temperature and heating time In
order to obtain the highest and most stable absorbance,
the effect of the reaction time and heating temperature
was investigated (Figure 6B). It was found that the reac-
tion proceeds very slowly at room temperature. A gra-
dual increase in the heating temperature produced a
significant increase in the absorbance of the reaction
product up to 70°C. Heating at 80°C resulted in precipi-
tation of the reagent. Therefore, the reaction was carried
out at 60°C for 15 min, which was adequate for com-
plete color development.
iv. Effect of diluting solvent The effect of different dilut-
ing solvent was tested using water, methanol, acetone,
acetonitrile, dimethylformamide, dimethylsulfoxide and
isopropanol. Using water as diluting solvent gives highest
absorbance value and best peak shape. Additionally, the
spectrum for ALD-DNFB in this solvent was found to be
shifted about 10 nm toward higher wavelength compared
to those in methanol, acetone, isopropanol and acetoni-
trile. On the other hand, dilution with dimethylformamide
and dimethylsulfoxide resulted in high blank reading.
Finally, water was chosen as the best diluting solvent.
v. Effect of time on the stability of the formed adduct
The reaction product was found to be stable for at least
60 min at room temperature.
Method III
According to the literature, the reaction of DNFB with
amines could be performed at room temperature or
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Figure 4 Effect of the volume of 0.2 M borate buffer on the reaction of: ■ ALD (15 μg/mL) with NBD-Cl, ▲ ALD (40 μg/mL) with DNFB
(method II), ● ALD (15 μg/mL) with DNFB (method III).
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micellar catalysis. It was
found that the micellar catalysis is useful not only in
speeding up the slow reaction of DNFB with ALD, and
thus adapting the time scale of the experiment, but also
in softening the experimental conditions required to
carry out the reaction, e.g. reducing the temperature and
the time for completion of the reaction. In addition, the
increase in the rate of the reaction is accompanied by an
increase in the apparent molar absorptivity, and therefore
the sensitivity and reliability of the procedure adapted.
Study of experimental parameters
The experimental conditions for the derivatization reac-
tion were optimized by the univariate method.
i. Effect of pH and volume of buffer The reaction was
investigated over the pH range of 7.0-11.0 using 0.2 M
borate buffer. It was found that increasing the pH
resulted in a corresponding increase in the absorbance
of the reaction product up to pH 9.5 after which it
remained constant. Therefore, pH 10.0 was chosen as
the optimal pH throughout this study (Figure 3). It was
found that increasing the volume of the buffer produces
a corresponding increase in the absorbance value of the
reaction product up to 0.5 mL, and it remained constant
up to 1.5 mL (Figure 4). Therefore, 1 mL was chosen as
the optimum buffer volume.
ii. Effect of concentration of DNFB solution The influ-
ence of the concentration of DNFB was studied using
different volumes of 0.3% v/v solution of the reagent. It
was found that increasing volumes of the reagent pro-
duce a proportional increase in the absorption intensity
up to 0.5 mL. However, no further increase in the
absorption intensity was observed upon increasing the
volume of the reagent up to 1.5 mL, after which further
increase produces a gradual decrease in the absorption
intensity. Therefore, 1.0 mL of 0.3% v/v DNFB solution
was chosen as the optimum volume of the reagent (Fig-
ure 5). To remove the excess reagent interference in the
absorbance measurement of the reaction product, 0.2
mL of concentrated HCl was added.
iii. Effect of concentration of cetrimide The optimal
cetrimide concentration required to catalyze the reaction
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Figure 5 Effect of the volume of reagent on the absorbance of the reactions products: ■ ALD (15 μg/mL) with NBD-Cl, ▲ ALD (40 μg/
mL) with DNFB (method II), ● ALD (15 μg/mL) with DNFB (method III).
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volumes of 1% w/v cetrimide solution to the reaction
mixture. It was found that 0.5-1.2 ml of 1% cetrimide
solution was suitable to develop the absorbance to its
maximum intensity. The absorption intensity decreased
with further increase in the volume of cetrimide solution.
0.8 mL of 1% w/v aqueous cetrimide solution was chosen
as optimal volume throughout this work (Figure 7).
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Figure 6 Effect of the heating time on the proposed reactions at different temperature settings. (A) ALD (15 μg/mL) with NBD-Cl, (B)
ALD (40 μg/mL) with DNFB (method II).
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presence of cetrimide relative to that in the non-micellar
aqueous medium at room temperature for longer time
(30 min) (Figure 8).
When cetrimide was replaced by anionic surfactant
(SDS) or nonionic surfactant (tween 80) no enhance-
ment of the sensitivity was observed relative to the non-
micellar medium.
iv. Effect of diluting solvent The effect of diluting sol-
vents other than water such as methanol, acetone, acet-
onitrile, dimethylformamide, dimethylsulfoxide and
isopropanol was also investigated to obtain the maxi-
mum color intensity. It was found that water, isopropa-
nol and acetonitrile are of similar effect. Meanwhile,
methanol, acetone, dimethylformamide and dimethyl-
sulfoxide slightly decreased the color intensity. Water
was selected as the optimal diluting solvent.
v. Effect of time on the formation and stability of the
formed adduct Maximum color development was
obtained within 5 min of mixing the reactants (Figure
8), and was stable for at least 60 min thereafter.
A summary for the optimization study of the variables
affecting the three proposed methods is given in Table 2.
Validation of the proposed methods
The validity of the proposed methods was tested regard-
ing linearity, range, limit of quantitation, limit of detec-
tion, accuracy, precision, robustness and specificity
according to ICH Q2(R1) recommendations [44].
Linearity and range
The calibration graphs obtained by plotting the values of
the absorbance versus the final concentrations (μg/mL)
were found to be rectilinear over the concentration
ranges cited in Table 1. The proposed methods were
evaluated for the accuracy as percent relative error (%
Er) and the precision as percent relative standard devia-
tion (% RSD) (Table 1). The validity of the proposed
methods were proven by statistical evaluation of the
regression line, using the standard deviation of the resi-
duals (Sy/x), the standard deviation of the intercept (Sa)
and standard deviation of the slope (Sb). The results are
abridged in Table 1. The small values of the figures
indicate low scattering of the points around the calibra-
tion line.
Limits of quantitation and limits of detection
The limits of quantitation (LOQ) were determined by
establishing the lowest concentrations that can be
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Figure 7 Effect of the volume of 1% cetrimide on the absorbance of the reaction product of ALD (15 μg/mL) with DNFB (method III).
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[44] below which the calibration graph is non linear.
The limits of detection (LOD) were determined also by
evaluating the lowest concentrations of the analytes that
can be readily detected. The results are summarized in
Table 1.
LOQ and LOD were calculated according to the fol-
lowing equations [44]:
LOQ = 10Sa/b
LOD = 3.3Sa/b
Where Sa is the standard deviation of the intercept of
regression line, and b is the slope of the regression line.
The obtained sensitivities were comparable to those
reported for other analytical techniques used for deter-
mination of ALD.
Accuracy
To test the validity of the proposed methods they were
applied to the determination of pure sample of ALD over
the concentration ranges cited in Table 3. The results
obtained were in good agreement with those obtained
using the comparison spectrophotometric method. Stu-
dent t- t e s ta n dt h ev a r i a n c er a t i oF-test [45] revealed no
significance differences between the performance of the
proposed and comparison methods regarding the accuracy
and precision, respectively (Table 3). The spectrophoto-
metric comparison method [7] depends on determination
of the studied drug through oxidation with ceric sulfate in
0.5 M sulfuric acid and subsequent measurement of the
excess unreacted cerium (IV) sulfate at 320 nm.
Precision
i. Repeatability The repeatability was tested by applying
the proposed methods for the determination of three
concentrations of ALD in pure form for three successive
times. The results are presented in Table 4.
ii. Intermediate precision Intermediate precision was
tested by repeated analysis of ALD in pure form using
the concentrations shown in Table 4 over a period of
three successive days. The results are also summarized
in Table 4.
Robustness
The robustness of the proposed methods is demonstrated
by the constancy of the absorbance with the deliberated
minor changes in the experimental parameters such as
change in pH (10.7 ± 0.2), change in the volume of buffer
(1 ± 0.5 mL), change in the volume of 0.2%w/v NBD-Cl
(1.2 ± 0.2), change in the heating temperature (70 ± 3°C)
and change in the heating time, 25 ± 5 min for method I.
Meanwhile, for method II these changes include; change
in pH (10.5 ± 0.5), change in the volume of the buffer
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Figure 8 Effect of the time on the reaction of ALD (15 μg/mL) with DNFB at room temperature: ● in presence of 0.8 mL of 1% w/v
cetrimide solution. ■ in absence of cetrimide.
Table 2 Assay parameters for the determination of ALD
by the three proposed methods
parameter Method I Method II Method III
Standard conc. (μg/mL) 200 400 300
Borate buffer pH 10.7 ± 0.2 10.5 ± 0.5 10.0 ± 0.5
Borate buffer volume (mL) 1 ± 0.5 1 ± 0.5 1 ± 0.5
Reagent conc. 0.2% w/v 0.3% v/v 0.3% v/v
Reagent volume (mL) 1.2 ± 0.2 1.2 ± 0.2 1.0 ± 0.5
Temperature (°C) 70 ± 5 60 ± 5 Room temp.
Time (min) 25 ± 5 15 ± 5 5
Stability of the product (min) 60 At least 60 At least 60
Diluting solvent methanol water water
lmax (nm) 472 378 374
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Page 10 of 15Table 3 Application of the proposed and comparison methods to the determination of ALD in pure form
Parameter Method I Method II Method III Comparison Method (7)
No of experiments 656 3
x ± S.D. 100.47 ± 1.12 100.17 ± 1.21 99.23 ± 1.26 100.55 ± 1.30
t 0.096 (2.365)* 0.420 (2.447)* 1.471 (2.365)*
F 1.347 (5.786)* 1.154 (6.944)* 1.064 (5.786)*
Each result is the average of three separate determinations
*Values between brackets are the tabulated t and F values, at P = 0.05 [45].
Table 4 Precision data of the proposed methods for the determination of ALD in pure form
Parameter Intra - day precision Inter - day precision
Conc. taken (μg/ml) Conc. found (μg/ml) % Found Conc. taken (μg/ml) Conc. found (μg/ml) % Found
5.00 4.927 98.50 5.00 4.948 98.96
Method I 10.00 9.958 99.58 10.00 9.999 99.99
15.00 15.022 100.17 15.00 15.138 100.92
‾x±S D 99.42 ± 0.85 99.96 ± 0.98
%RSD 0.85 0.98
%Er 0.49 0.57
12.00 11.97 99.73 12.00 11.88 98.99
Method II 16.00 16.26 101.63 16.00 15.84 99.01
20.00 20.42 102.13 20.00 19.96 99.81
‾x±S D 101.16 ± 1.27 99.27 ± 0.47
%RSD 1.26 0.47
%Er 0.73 0.27
3.00 2.978 99.28 3.00 2.957 98.55
Method III 15.00 14.928 99.52 15.00 14.987 99.91
30.00 30.096 100.32 30.00 29.926 9975
‾x±S D 99.71 ± 0.54 99.40 ± 0.74
%RSD 0.54 0.74
%Er 0.31 0.43
Table 5 Application of the proposed and comparison methods to the determination of ALD in tablet dosage forms
Pharmaceutical
preparation
Method I Method II Method III Comparison method
(7)
Conc. taken (μg/
mL)
%
Found
Conc. taken (μg/
mL)
%
Found
Conc. taken (μg/
mL)
%
Found
Osteonate
® tablets 10.00 99.24 16.00 99.92 18.00 98.17 101.16
(13.05 mg
ALD/tablet)
a
15.00
20.00
98.41
97.51
20.00
40.00
97.50
99.08
24.00
30.00
97.88
100.70
102.67
99.65
‾ x ± S.D. 98.39 ± 0.87 98.83 ± 1.23 98.92 ± 1.55 101.16 ± 1.51
t 2.756 (2.776)* 2.073 (2.776)* 1.792 (2.776)*
F 3.012 (19.00)* 1.507 (19.00)* 1.064 (19.00)*
Alendex
® tablets 10.00 101.67 16.00 100.25 18.00 101.67 97.21
(52.2 mg
ALD/tablet)
b
15.00
20.00
98.32
100.34
20.00
40.00
99.83
98.85
24.00
30.00
98.65
99.81
101.00
99.25
‾ x ± S.D. 100.11 ± 1.67 99.64 ± 0.72 100.04 ± 1.52 99.15 ± 1.90
t 0.655 (2.776)* 0.409 (2.776)* 0.422 (2.776)*
F 1.294 (19.00)* 6.964 (19.00)* 1.054 (19.00)*
Each result is the average of three separate determinations
*Values between brackets are the tabulated t and F values, at p = 0.05 [45]
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Page 11 of 15(1 ± 0.5 mL), change in the volume of 0.3% v/v DNFB
(1.2 ± 0.2 mL), change in the heating temperature (60 ±
5°C) and change in the heating time (15 ± 5 min). For
method III these changes include; change in pH (10.0 ±
0.5), change in the volume of the buffer (1 ± 0.5 mL),
change in the volume of 0.3% v/v DNFB solution (1.0 ±
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Figure 9 Limiting logarithmic plots for the molar reactivity of ALD with the two proposed reagents: (A) log A vs log [reagent] with
[ALD] kept constant; (B) log A vs log [ALD] with [reagent] kept constant; Where, ■ Method I (NBD-Cl method), and ● Method II (DNFB
method).
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Page 12 of 150.5 mL), and change in the volume of 1% w/v cetrimide
solution (0.8 ± 0.3 mL). These minor changes that may
take place during the experimental operation didn’t affect
the absorbance of the reactions products.
Specificity
The specificity of the methods was investigated by
observing any interference encountered from the com-
mon tablet excipients. These excipients did not interfere
with the proposed methods.
Pharmaceutical applications
The proposed methods were successfully applied to
determine the studied drug in its pharmaceutical pre-
parations. The results obtained were statistically com-
p a r e dt ot h o s eo far e p o r t e dm e t h o d[ 7 ]b ys t u d e n t ’s t-
test and variance ratio F-test as shown in Table 5. The
experimental values of t and F did not exceed the theo-
retical values, indicating lack of significant difference
between the compared methods.
Molar ratio and mechanism of the proposed reactions
The stoichiometry of the two reactions was studied
adopting the limiting logarithmic method [46]. For the
two reactions, two straight lines were obtained using
increasing concentrations of the reagent while keeping
the concentration of the drug constant and using
increasing concentrations of the drug while keeping the
concentration of the reagent constant. Plots of log
absorbance versus log [NBD-Cl] and log [ALD] gave
two straight lines, the slopes of which were 0.9208/
0.8597, respectively (Figure 9). Hence, it is concluded
that the reaction proceeds in the ratio of 1:1, confirming
that one molecule of the drug condenses with one mole-
cule of NBD-Cl.
Method II was applied for the determination of the
stoichiometry of the reaction of ALD and DNFB. Plots
of log absorbance versus log [DNFB] and log [ALD]
gave straight lines; the values of their slopes were 0.9157
and 0.9666, respectively (Figure 9). Hence, it is con-
cluded that the reaction proceeds in the ratio of 1:1,
confirming that one molecule of the drug condenses
with one molecule of DNFB.
Based on the observed molar ratios, proposed reaction
pathways are given in schemes 1 and 2, respectively.
The micellar catalytic effect of the cationic surfactant,
cetrimide, on the reaction of ALD with DNFB may be
explained on the basis of electrostatic interactions. ALD
features 5 negative charges, so it will be electrostatically
attracted to the oppositely charged micelles of cetrimide,
and thereby brought closer to DNFB reagent that’sp r e -
ferentially solubilized by the micelles, thus contributing
to acceleration of the reaction [47].
Critical comparison of the three developed methods
The critical comparison of the three developed spectro-
photometric methods for the determination of ALD
leads to the following advantages/disadvantages:
1. All methods are sufficiently sensitive and selective
for the determination of the analyte in its pharmaceuti-
cal formulations.
2. The linearity and sensitivity are best for Method I.
M e a n w h i l e ,m e t h o dIa n dm e t h o dI I Io f f e rt h ew i d e s t
determination range (1.0-20.0 μg/mL for method I and
1.5-30.0 μg/mL for method III).
3. The third method offers the shortest reaction time
(5 min)
4. The second and third methods employ simpler
diluting solvent (water versus methanol for third
method) providing cost effectiveness
Other techniques such as capillary electrophoresis and
HPLC may also give good results but, because of the low
cost and ease of carrying out the spectrophotometric
methods, the
proposed procedures are likely to be very suitable for
the quality control of ALD in tablet dosage form.
Conclusion
The proposed spectrophotometric methods provided sen-
sitive, specific and inexpensive analytical procedures for
determination of the non-chromophoric drug alendronate
either per se or in its tablet dosage forms without interfer-
ence from common excipients. Moreover, the developed
methods are less time-consuming and do not require
elaborate treatments associated with chromatographic
NH
H
R +
N
O
N
NO2
Cl
N
O
N
NO2
N
H R
+ HCl
NBD-Cl ALD
pH 10.7
Scheme 1 Proposed reaction pathway between NBD-Cl and ALD
under the described reaction conditions.
R NH +
F
NO2
NO2
NH
NO2
NO2
R
+ HF
H
      ALD                          DNFB
Scheme 2 Proposed reaction pathway between DNFB and ALD
under the described reaction conditions.
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Page 13 of 15methods. These attributes, in addition to the satisfactory
sensitivity and reproducibility as well as the convenience
and simplicity, make the three proposed methods suitable
for routine analysis in quality control laboratories.
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